Chevy Chase Trust
GH icon

Chevy Chase Trust’s Guardant Health GH Stock Holding History

Chevy Chase Trust’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40,549
Closed -$2.69M – 636
2022
Q1 		$2.69M Sell
40,549
-544,048
-93% -$37.2M 0.01% 535
2021
Q4 		$58.5M Sell
584,597
-7,368
-1% -$762K 0.19% 113
2021
Q3 		$74M Buy
591,965
+2,680
+0.5% +$318K 0.26% 98
2021
Q2 		$73.2M Buy
589,285
+21,137
+4% +$2.84M 0.25% 98
2021
Q1 		$86.7M Buy
568,148
+6,386
+1% +$965K 0.31% 79
2020
Q4 		$72.4M Buy
561,762
+31,690
+6% +$3.65M 0.26% 92
2020
Q3 		$59.3M Buy
530,072
+103,726
+24% +$9.49M 0.23% 98
2020
Q2 		$34.6M Buy
426,346
+63,313
+17% +$5.1M 0.14% 158
2020
Q1 		$25.3M Buy
+363,033
New +$27.9M 0.12% 174

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Chevy Chase Trust's GH Position: Q2 2022 in Review

Chevy Chase Trust sold out of Guardant Health (GH) in Q2 2022, closing a stake of 40,549 shares — an estimated $2.69M sold.

Chevy Chase Trust first reported a position in GH in Q1 2020 and held it in 9 quarters. The position peaked at $86.7M in Q1 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • Chevy Chase Trust reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
  • Chevy Chase Trust sold 40,549 Guardant Health shares in Q2 2022, an estimated $2.69M.
  • Chevy Chase Trust first reported a position in Guardant Health in Q1 2020 and held it in 9 quarters.
  • Chevy Chase Trust's Guardant Health position peaked at $86.7M in Q1 2021.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Chevy Chase Trust's 13F filing for Q2 2022, filed 10 Aug 2022.